RADX
RADX clinical trials: Radiopharm Theranostics Ltd
Every trial on ClinicalTrials.gov where Radiopharm Theranostics Ltd is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 7
- Trials linked
- 7
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
RADX on the catalyst calendar · RADX registry changes
- Primary completion Dec 2027Sponsor estimateEarly Phase 1NCT06305962177Lu-anti-PD-L1 sdAb in Metastatic Solid TumorsRadiopharm Theranostics, Ltd · PDL1 Gene MutationRecruitingRADXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2027Sponsor estimatePhase 1/Phase 2NCT07189871177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid TumorsRadiopharm Theranostics, Ltd · Castration-Resistant Prostate Cancer (CRPC)RecruitingRADXLeadMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2027Sponsor estimateEarly Phase 1NCT06824155HEAT Trial (HER2 Antibody Therapy With Lutetium-177)Radiopharm Theranostics, Ltd · HER2 Gene MutationRecruitingRADXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2026Sponsor estimatePhase 1NCT05799274Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid TumorsRadiopharm Theranostics, Ltd · Healthy VolunteersActive, not recruitingRADXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 30, 2027Sponsor estimatePhase 1NCT07272642A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors.Radiopharm Theranostics, Ltd · ImagingNot yet recruitingRADXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 23, 2026ActualPhase 2NCT06777433Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain MetastasesRadiopharm Theranostics, Ltd · Brain Metastases From Solid TumorsActive, not recruitingRADXLeadMEDPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 30, 2028Sponsor estimatePhase 1/Phase 2NCT07259213A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPCRadiopharm Theranostics, Ltd · Castration-resistant Prostate CancerRecruitingRADXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 7 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner